1Wang Y X, Li Z F, Li G W, et al. Effect of spleenomegaly and splendid macrophage activity in hypersplenisrn due to cirrhosis[J]. AM J Med, 2002, 113(5): 428.
2Yah F, Zhao J, Ma J C, et al, Metabolic effects of a novel bin artificial liver on serum from severe hepatitis patients: an in vitro study[J]. Chin Med J (Engl), 2003, 116(10) : 1471.
4Mitsuhasbi n, Takahasbi T, Scikruai H, et al. Establishment and characterization of a new human lung poorly differentiated aden carcinoma cell line, G Ⅱ -1 producing carcinoembryonic antigen(CEA) and CM99[J]. Lung cancer, 1995, 12: 13.
5Bonnet J A, Sloan J A, Rowland K M J, et al. Significance of neuron specific enclose levels before and during therapy for small cell lung cancer[J]. Clin Cancer Res, 2000, 6(2) : 597.
6Bonner J A. Rowland K M. et al. Significance of neuronspecific enclose levels before and during therapy for small cell lung cancer[J]. Clin Cancer Res, 2000, 6(2): 597.
6Spira A, Ettinger DS. Multidisciplinary management of lung cancer[J]. N EnglJ Med,2004,350 (4):379- 392.
7Chen G, Gharib TG, Huang CC, et aI. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors [J]. Clin Cancer Res,2002,8 (7) :2298-2305.
8Chen F, Li WM, Wang DM, et al. Clinical value of combined detection of serum tumor markers in lung cancer diagnosis[J]. Sichuan Da Xue Xue Bao (Yi Xue Ban),2008,39 (5):832-835.
9Shitrit D, Zingerman B, Shitrit AB, et al. Diagnostic value of CYFRA 21 -1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature[J]. Oncologist,2005,10 (7) :501-507.
10Satoh H, Ishikawa H, Kurishima K, et al. Cut-off levels of NSE to differentiate SCLC from NSCLC[J]. Oncol Rep,2002,9 (3) :581-583.
